| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.80▼ | 5.83▼ | 5.83▼ | 5.95▼ | 6.51▼ |
| MA10 | 5.81▼ | 5.86▼ | 5.86▼ | 6.24▼ | 6.40▼ |
| MA20 | 5.85▼ | 5.94▼ | 5.93▼ | 6.62▼ | 6.60▼ |
| MA50 | 5.96▼ | 6.05▼ | 6.19▼ | 6.41▼ | 9.08▼ |
| MA100 | 6.11▼ | 6.47▼ | 6.63▼ | 6.64▼ | N/A |
| MA200 | 6.50▼ | 6.74▼ | 6.36▼ | 8.45▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | -0.003▼ | 0.006▲ | -0.121▼ | 0.103▲ |
| RSI | 39.943▼ | 38.962▼ | 38.391▼ | 36.888▼ | 40.476▼ |
| STOCH | 12.933▼ | 16.353▼ | 12.903▼ | 6.097▼ | 49.390 |
| WILL %R | -85.000▼ | -90.476▼ | -92.500▼ | -98.558▼ | -72.703 |
| CCI | -98.967 | -133.165▼ | -110.348▼ | -106.021▼ | -94.510 |
|
Tuesday, April 29, 2025 01:05 PM
FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to ...
|
|
Tuesday, April 29, 2025 09:05 AM
The issuer is solely responsible for the content of this announcement. Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active ...
|
|
Monday, April 28, 2025 05:00 PM
Marc de Garidel is the CEO of Abivax. Mr. de Garidel joined Abivax in May 2023. Prior to that, he led the successful sale of CinCor Pharma for up to US$1.8B, subject to the achievement of certain ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/05/25 | 5.81 | 5.87 | 5.75 | 5.78 | 39,717 |
| 19/05/25 | 6.10 | 6.10 | 5.79 | 5.88 | 137,564 |
| 16/05/25 | 5.99 | 6.225 | 5.925 | 6.01 | 120,156 |
| 15/05/25 | 6.00 | 6.15 | 5.90 | 5.99 | 33,752 |
| 14/05/25 | 6.18 | 6.34 | 5.945 | 6.10 | 69,032 |
| 13/05/25 | 6.33 | 6.33 | 6.00 | 6.04 | 57,289 |
| 12/05/25 | 6.34 | 6.635 | 6.245 | 6.40 | 94,849 |
| 09/05/25 | 6.98 | 6.99 | 6.655 | 6.71 | 17,236 |
| 08/05/25 | 6.87 | 7.04 | 6.62 | 6.85 | 83,899 |
| 07/05/25 | 6.80 | 7.05 | 6.54 | 6.625 | 52,519 |
|
|
||||
|
|
||||
|
|